Patent ID: 11891395
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 13:
14. A compound selected from the group consisting of:
N-(3-chlorophenyl)pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-amine (1),
N-(m-tolyl)pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-amine (2),
N,N-dimethyl-3-(pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-ylamino)benzamide (3),
N1,N1-dimethyl-N3-(pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-yl)benzene-1,3-diamine (4),
N-(3-methoxyphenyl)pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-amine (5),
3-(pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-ylamino)phenol (6),
N-(3,5-dimethylphenyl)pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-amine (7),
N-(3,5-dichlorophenyl)pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-amine (8),
N-(2-methylpyridin-4-yl)pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-amine (9),
N-(3-chlorobenzyl)pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-amine (10),
N-(pyridin-3-ylmethyl)pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-amine
N1,N1-dimethyl-N3-(pyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridin-5-yl)propane-1,3-diamine (12),
and a pharmaceutically acceptable salt, ester, stereoisomer, or solvate thereof.